IV Dosing, Wt-Based
Weight‑based IV dosing means adjusting the intravenous drug dose proportionally to the patient’s body weight to optimize safety and efficacy.
Indikationen
Use weight‑based IV dosing when drug distribution and clearance correlate with body size (eg, anticoagulants, thrombolytics, many pediatric emergency drugs). Clinical utility: improves target drug exposure, reduces underdosing or toxicity, and standardizes dosing across weights. Evidence: weight‑based enoxaparin achieves superior anti‑Xa levels versus fixed dosing in critically ill patients 1 [Level I evidence]; full weight‑based chemotherapy dosing maintains efficacy in obese adults without increased toxicity 2 [Level II evidence].
Hinweise & Vorsichtsmaßnahmen
Use actual weight when known, but confirm accuracy; in emergencies, length‑based tools often underestimate weight by 10–20% 1 [Level I evidence]. Avoid automatic dose increases in obesity—data show no proven safety for adjusted‑weight strategies and risk of inaccurate dosing 2 [Level II evidence]. Monitor renal function closely for renally cleared medications. For narrow‑therapeutic‑index drugs, titrate to clinical effect or drug levels.